$CAST

Jefferies lifts Castellum on buyback drive despite weak office market By Investing.com

Jefferies upgraded Castellum AB to hold from underperform and raised its price target to SEK125 from SEK105, citing planned SEK15.6 billion share buybacks in 2026-27 (25% of Dec 2025 shares) and revised forecasts. Jefferies expects EPS of SEK8.45 for 2026 and notes weak office demand, with 2026-27 credit metrics remaining tight.

Original reporting
Published Jul 20, 2026, 10:01 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 20, 2026, 10:24 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$CAST
Bullish
medium confidence
Mentioned
$CAST
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$CASTBullishMed
01

Why it matters

Jefferies’ upgrade and PT increase are explicitly tied to a large, scheduled buyback program and updated revenue/EPS assumptions, while the office market remains sluggish with negative net leasing dynamics and tight forward credit metrics.

02

Market read

For CAST, the actionable change is the broker’s rating and PT, supported by a quantified buyback plan, but tempered by leasing weakness and tight 2027 credit metrics.

03

What to watch

The article notes 2027 credit metrics are tight (EPRA LTV 53.7%, interest coverage 2.4x, net debt/EBITDA 11x). If refinancing costs rise or leasing worsens, buyback support could reverse.

Relevance 7/10Novelty 6/10Timing: today, ahead of the next trading session as the broker upgrade and PT reset hit the tape

Background

Castellum is pursuing a return-on-equity-led capital recycling strategy, selling assets that fail a 10% ROE requirement and returning proceeds via buybacks and debt reduction.

Company-level read

Ticker impact

$CASTBullishMedium confidence
Context

Jefferies upgraded Castellum AB to hold and raised its PT to SEK125, citing SEK15.6B buybacks in 2026-27 to support the stock short term.

Expected impact

Near-term downside may be cushioned by the announced buyback schedule, but valuation and leasing trends could cap upside if net leasing stays weak.

Evidence & confidence

The article provides a concrete broker action (upgrade, PT change) plus specific capital-return and leasing/credit-metric details that shape the risk-reward for CAST.

Market effects

Highlights how European office landlords may use capital recycling and buybacks to offset weak leasing, keeping focus on ROE thresholds and credit metrics.

Relevant to Swedish real estate sentiment, where buyback announcements can temporarily stabilize pricing despite rising vacancy.

Limited beyond the European office REIT/real-estate complex, unless buyback-led support becomes a broader read-across theme.

Counterpoint

Buybacks may not fix the core issue: negative net leasing and rising vacancy imply cash flows could deteriorate, making the stock vulnerable if credit metrics tighten further.

Key entities

  • Castellum AB

    Swedish office real estate company; subject of Jefferies upgrade, PT raise, and buyback/capital recycling details.

  • Jefferies

    Issued the upgrade from underperform to hold and raised the price target to SEK125.

  • AP7

    Buyback deal counterparty referenced for a SEK3.4B buyback in H1 2026.

  • Alecta

    Referenced for a sale that funded a SEK3.0B buyback launched this week.

Related articles

$CASTMed

Why is Castellum stock sliding today? By Investing.com

Investing.com reports Castellum AB shares fell 4.7% to SEK 126.6. UBS downgraded Castellum from Buy to Neutral, saying about 25% YTD gains and prior rerating drivers, including over SEK 20bn in disposals and buybacks, are largely priced in. Barclays upgraded to Equal Weight and raised its target to SEK 130 but cut 2026 EPS by 8% and 2027 by 7%.

$CASTMed

Castro secures franchise of Chinese sports goods giant Anta

Castro Model (TASE: CAST) said it signed a five-year franchise agreement with China’s Anta Sports Products to distribute and sell Anta in Israel. The deal includes wholesale licensing, dedicated stores, and a local website, with estimated investment of NIS 30m and start in 2027. Castro may seek partners for up to 49% of a subsidiary; Anta is HK-listed with 2025 revenue of $11.6b.

$CASTMedAI 8/10

FreeCast Stock Falls As Investors Weigh $23.7 Million Private Capital Raise - FreeCast (NASDAQ:CAST)

FreeCast (NASDAQ:CAST) shares fell after the company announced a $23.7M private placement. It plans to sell 4,666,667 Class A shares and pre-funded warrants for 3,243,807 shares at a $0.0001 exercise price, exercisable after shareholder approval. Proceeds will fund working capital; closing expected July 2, 2026. Analysts project an Aug. 14 loss of $0.08/share on $100.8M revenue.

$CASTMedAI 8/10

Benzinga

FreeCast Inc. (NASDAQ:CAST) said partners can add DIRECTV to its branded streaming, broadband, wireless, community, hospitality and residential solutions. The company extended gains after expanding its DIRECTV relationship, enabling DIRECTV streaming without a home satellite dish and through existing sales channels. CAST shares last traded at $4.57, up 163% on the day; the article cites a $6.00 average price target and an Aug. 14, 2026 estimated earnings date.

$MRNAMedAI 8/10

Moderna stock pulls back after massive one-day rally: analysts weigh in

Moderna (MRNA) shares fell over 10% in premarket trading after a 177% rally on positive melanoma vaccine trial data with Merck (MRK). Merck shares also slipped over 1%. Bank of America upgraded Moderna to Neutral, raising its price target to $170, citing the potential for diversification. Merck's Buy rating was reaffirmed with a $166 target. Both companies' stocks were impacted by the trial results.